Lupin

“The VISUfarma acquisition marks a very exciting milestone for Lupin, adding a differentiated portfolio of more than 60 innovative eye health products supported by an established commercial infrastructure. Beyond being immediately…
Read More...

“This recognition by S&P Global places Lupin among the topmost global sustainability leaders and reinforces our long-term commitment to embedding ESG principles into our business strategy.” Ramesh Swaminathan, Executive Director, Global…
Read More...